COVID-19 with rheumatic diseases: a report of 5 cases Chuanfang ChengChuanjing LiXiaoan Liu Case Based Review 14 May 2020 Pages: 2025 - 2029
Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review Jinghong DaiYali XiongJian Tang Case Based Review 25 May 2020 Pages: 2031 - 2037
Navigating COVID-19 in the developing world Bridget HodkinsonPrasun SinghDeshiré Alpízar-Rodríguez Editorial 27 May 2020 Pages: 2039 - 2042
The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress Martina OrlandiGemma LepriSilvia Bellando-Randone Editorial 08 June 2020 Pages: 2043 - 2047
YouTube as a source of information on COVID-19 and rheumatic disease link Burhan Fatih KocyigitMazlum Serdar AkaltunAhmet Riza Sahin Original Article 23 May 2020 Pages: 2049 - 2054
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets Durga Prasanna MisraVikas AgarwalOlena Zimba Perspectives in Rheumatology 10 April 2020 Pages: 2055 - 2062
Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity Antonina MinnitiWanda MaglioneNicoletta Del Papa Perspectives in Rheumatology 27 May 2020 Pages: 2063 - 2065
Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? Kiana Vakil-GilaniKenneth O’Rourke Perspectives in Rheumatology 30 May 2020 Pages: 2067 - 2068
COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments Dieu-Donné OuédraogoWendlassida Joelle Stéphanie TiendrébéogoHonoré Ntsiba Review Article 29 May 2020 Pages: 2069 - 2075
Treatment algorithm for COVID-19: a multidisciplinary point of view Felice GalluccioTolga ErgonencMario Fajardo-Pérez Review Article 29 May 2020 Pages: 2077 - 2084
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment Mehmet SoyGökhan KeserServet Kayhan Review Article 30 May 2020 Pages: 2085 - 2094
High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia Carmine GazzarusoNicoletta Carlo StellaPietro Gallotti Letters of Biomedical and Clinical Research 27 May 2020 Pages: 2095 - 2097
Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? Sakir AhmedPrajna Anirvan Letter to the Editor 09 May 2020 Pages: 2099 - 2100
Colchicine may not be effective in COVID-19 infection; it may even be harmful? Medine Cumhur CureAdem KucukErkan Cure Letter to the Editor 11 May 2020 Pages: 2101 - 2102
Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis Adem KucukMedine Cumhur CureErkan Cure Letter to the Editor 26 May 2020 Pages: 2103 - 2104
Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2 C. Sieiro SantosC. Nogal AriasT. Perez Sandoval Letter to the Editor 04 June 2020 Pages: 2105 - 2106
Professor Luis R. Espinoza: a living legacy (1943–2020) Luis J. JaraAde AdebajoCarlos Pineda In Memoriam 06 June 2020 Pages: 2107 - 2110
Catastrophic antiphospholipid syndrome: is life-long anticoagulation therapy required? Christopher J. MesaEileen C. RifeLuis R. Espinoza Brief Report 27 February 2020 Pages: 2115 - 2119
Serum adipokine levels in patients with sarcoidosis Senol KobakHuseyin SemizHuseyin Vural Original Article 14 February 2020 Pages: 2121 - 2125
Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis Jeffrey KaineJohn TesserJürgen Wollenhaupt Original Article Open access 12 February 2020 Pages: 2127 - 2137
Relative efficacy and safety of iguratimod monotherapy for the treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis Sajan ShresthaJing ZhaoJinping Zhang Original Article 20 February 2020 Pages: 2139 - 2150
The role of socioeconomic status in the susceptibility to develop systemic lupus erythematosus in Mexican patients Norma Alicia Salgado-GaliciaSusana Hernández-DoñoJulio Granados Original Article 01 February 2020 Pages: 2151 - 2161
Prevalence of anti-DFS70 autoantibodies in a Latin American cohort of patients with systemic lupus erythematosus and without autoimmune diseases Cristian C. AragónIván Posso-OsorioGabriel J. Tobón Original Article 22 February 2020 Pages: 2163 - 2169
Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies Katsuaki AsakawaKazutaka YoshizawaToshinori Takada Original Article 13 February 2020 Pages: 2171 - 2178
Diagnosing relapsing polychondritis remains a common challenge: experience from a Chinese retrospective cohort Lei ZhangTian-Ge WuTian-Fang Li Original Article 08 February 2020 Pages: 2179 - 2184
Central nervous system involvement in patients with antineutrophil cytoplasmic antibody–associated vasculitis: a study of 29 cases in a single Chinese center Tian-Tian MaZhi-Ying LiMing-Hui Zhao Original Article 16 February 2020 Pages: 2185 - 2193
Impact of thumb osteoarthritis on pain, function, and quality of life: a comparative study between erosive and non-erosive hand osteoarthritis Sara TentiFabio FerrettiAnna Coluccia Original Article 22 February 2020 Pages: 2195 - 2206
Clinical phenotypes based on clinical prognostic factors in patients with secondary hip osteoarthritis: preliminary findings from a prospective cohort study Hiroshige TateuchiHaruhiko AkiyamaNoriaki Ichihashi Original Article 22 February 2020 Pages: 2207 - 2217
TNF inhibitor treating osseous sarcoidosis and dactylitis: case and literature review Diala AlawnehAhmad Al-ShyoukhAmr Edrees Case Based Review 04 February 2020 Pages: 2219 - 2222
Orbital compartment syndrome as the first manifestation of SLE Maria ColonLara El Khoury Case Based Review 09 March 2020 Pages: 2223 - 2226
A tale of autoimmunity: thymoma, thymectomy, and systemic lupus erythematosus Arash MollaeianChristopher Haas Case Based Review Open access 10 April 2020 Pages: 2227 - 2234
Spatio-temporal evolution of onychomadesis in a child with missed Kawasaki disease Aaqib Zaffar BandayHarsha NeelamAnkur Kumar Jindal Clinical Image 24 April 2020 Pages: 2237 - 2238
Apolipoprotein C1 in synovial fluid discriminates septic arthritis from rheumatoid arthritis but not from pseudogout Margot ClapassonCandice TrocméAthan Baillet Letters of Biomedical and Clinical Research 12 April 2020 Pages: 2239 - 2241
Comment on “A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis” Ivna Akrapovic OlicMislav Radic Letter to the Editor 24 April 2020 Pages: 2243 - 2244
Correction to: Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis Rosa Elda Barbosa-CobosGustavo Lugo-ZamudioJosé Moreno Correction 08 May 2020 Pages: 2245 - 2245
Correction to: A systematic review of internet-based information for individuals with Raynaud’s phenomenon and patients with systemic sclerosis Vikrant DevgireAndreas Flores MartinMichael Hughes Correction 11 May 2020 Pages: 2247 - 2247
Correction to: Associations between serumIL-8 and knee symptoms, joint structures, and cartilage or bone biomarkers in patients with knee osteoarthritis Guangfeng RuanChanghai Ding Correction 28 May 2020 Pages: 2249 - 2249
